
Novartis Spinoff Sandoz to Start Trading as Standalone Drugmaker
Sandoz Group AG, the maker of copycat medicines, was spun off from drugmaker Novartis AG to begin life
2023-10-04 16:18

China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US
As drugmakers in the US steel for price negotiations ushered in by President Joe Biden’s Inflation Reduction Act,
2023-08-03 10:19

Eisai Appoints CEO’s 34-Year-Old Son to Lead Global Alzheimer Drug Program
Japanese drug giant Eisai Co. said global Alzheimer drug program officer Ivan Cheung will retire at the end
2023-07-11 11:19

How a Japanese Drugmaker Clinched Win Over Alzheimer’s
(This story was originally published Sept. 29. On Thursday, the US Food and Drug Administration granted full approval
2023-07-07 08:56

Eisai Alzheimer's Drug Gets Full US Approval, Widening Access to the Therapy
Eisai Co.’s Alzheimer’s drug Leqembi gained full approval from US regulators, a move that will help widen insurance
2023-07-07 08:53

Teva Plans to Cut Back Generic Drug Production Even As Shortages Intensify
Teva Pharmaceutical Industries Ltd. plans to cut back manufacturing of generic drugs, citing low profitability, at a time
2023-05-19 05:29